NOVEL METHODS OF DIAGNOSING BREAST CANCER, COMPOSITIONS, AND METHODS OF SCREENING FOR BREAST CANCER MODULATORS

Details for Australian Patent Application No. 2002249871 (hide)

Owner EOS BIOTECHNOLOGY, INC.

Inventors GISH, Kurt, C.; MACK, David

Pub. Number AU-A-2002249871

PCT Pub. Number WO2002/055988

Priority 09/747,371 21.12.00 US

Filing date 21 December 2001

Wipo publication date 24 July 2002

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002249871

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002249872-Substituted triazole diamine derivatives as kinase inhibitors

2002249870-Inhibitors of prenyl-protein transferase